RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 1936 - per page Next page
Order by
Direct amplification from whole blood without DNA isolation / AnyDirect PCR buffer
Direct gene amplification using AnyDirect solution gives reliable results from crude biospecimens without DNA isolation or any instrument. More
Efficient Gene Silencing Using tRNA Promoter in a Herpes Virus Vector to Deliver Small Interference RNAs (05-07)
An siRNA type therapeutics delevary system More
Medical Device for the Evaluation of Motor Development in Infants (TID - 153)
The early detection and treatment of motor developmental delays in infants is critical to future motor skill function. More
Diagnostics and Therapeutics for Hydrocephalus
The present invention provides assays for the detection of human RFX4_v3 polymorphisms or deficiencies that may lead to the determination of an individual's risk of developing hydrocephalus. More
Extracellular Matrix Gene Chips to Detect Metastatic Tumors
These gene chips detect the over-expression of the cancer-related extracellular matrix (ECM) modifier proteins Anakin and Bromodomain 4 (Brd4). More
Rapid and Sensitive Detection of Nucleic Acid Sequence Variations
Mismatch-targeted transposition of Mu: a new strategy to map genetic polymorphism. More
Over-expression and Mutation of a Tyrosine Kinase Receptor FGFR4 in Tumors
Identification of mutations in fibroblast growth factor receptor 4 (FGFR4) that are associated with Rhabdomyosarcoma tumors; may be used to identify candidates for treatment with an FGFR4 inhibitor as an adjuvant to standard anticancer therapy. More
Premenstrual Symptoms Screening Tool (PSST): To Identify Women who Suffer from Severe Premenstrual Syndrome or Premenstrual Dysphoric Disorder
Premenstrual Symptoms Screening Tool (PSST): To Identify Women who Suffer from Severe Premenstrual Syndrome or Premenstrual Dysphoric Disorder More
Gene Signature for Predicting Hepatocellular Carcinoma Patient Prognosis
A method of predicting the prognosis of a patient diagnosed with HCC by detecting expression of one of more HCC-associated genes, and a method of identifying an agent for use in treating HCC More
Predictive Medicine: Risk-adapted Therapy in Multiple Myeloma with combined abnormal Chromosomes 1 and 13 Confers Resistance to Thalidomide in Total Therapy 2 and is linked to Hyper-expression of the IL6R Gene in Malignant Plasma Cells (09-29)
Thalidomide has been successfully used to successfully treat myeloma patients however, patients with high IL6R expression levels via gene expression profiling, do not benefit from the use of this drug. Therefore, the use of anti-IL6R therapies in combina More
Displaying 1..10 of 1936 - per page Next page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Diagnostics Partnering Terms and Agreements
Feb 2012 - 1350 pages - $2,695
Veterinary Diagnostics Markets
Oct 2009 - 30 pages - $995
Companion Diagnostics Partnering Terms and Agreements
Apr 2011 - 250 pages - $2,695
Molecular Diagnostics: Market Landscape
Nov 2011 - 50 pages - $3,800
Population Diagnostics Inc. - Product Pipeline Analysis
Mar 2011 - 15 pages - $750
The Future of In Vitro and In Vivo Diagnostic Integration
Jan 2011 - 130 pages - $3,835
Genetic Immunity, LLC – Product Pipeline Review – Q1 2011
Apr 2011 - 26 pages - $500
Personalized Medicine Partnering Terms and Agreements
Apr 2011 - 951 pages - $4,995
Global In-Vitro Diagnostics Market Trends
Jan 2011 - 10 pages - $500
Advances in Drug-Diagnostic Co-Development
May 2011 - 102 pages - $3,835
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us